Pethidine revisited: plasma concentrations and effects after intramuscular injection

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Pain Management

Background:

• Pethidine (an opioid analgesic) is commonly administered via intramuscular injection.
• Understanding its pharmacokinetic and pharmacodynamic profile is crucial for effective pain management.
• Variations in drug absorption and patient response can impact clinical outcomes.

Purpose of the Study:

• To compare plasma concentrations of pethidine following intramuscular gluteal injection in surgical patients and healthy volunteers.
• To investigate the relationship between plasma pethidine levels and subjective effects in both groups.
• To assess the influence of patient-specific factors on pethidine pharmacokinetics and response.

Main Methods:

• Intramuscular gluteal injection of pethidine.
• Measurement of plasma pethidine concentrations over time.
• Assessment of subjective patient effects.
• Comparison between surgical patients and healthy volunteers.

Main Results:

• Mean plasma pethidine concentrations were generally higher in surgical patients compared to volunteers.
• Absorption of at least 80% of the pethidine dose occurred within 6 hours.
• Observed fluctuations in plasma concentrations, more pronounced in patients, likely due to blood flow variations.
• Volunteer subjective effects correlated with peak plasma concentrations, but patients showed reduced sensitivity.

Conclusions:

• Surgical patients may exhibit altered pethidine absorption kinetics compared to volunteers.
• Blood flow variability can influence pethidine plasma concentration fluctuations.
• Plasma pethidine concentrations may not reliably predict clinical response in surgical patients due to factors like catecholamine-mediated stimulus.